| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $290.3M | +1.0% |
| R&D Expense | $63.3M | +3.2% |
| SG&A Expense | $40.3M | +44.3% |
| Operating Income | -$28.1M | -839.2% |
| Pre-tax Income | -$23.6M | -325.4% |
| Income Tax | -$5.8M | -2161.6% |
| Net Income | -$17.8M | -265.6% |
| EPS (Basic) | -$0.14 | -240.0% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.0M | -37.2% |
| Accounts Receivable | $25.0M | +21.8% |
| Current Assets | $176.0M | -27.2% |
| Total Assets | $352.0M | +5.1% |
| Current Liabilities | $34.2M | +14.2% |
| Total Liabilities | $49.7M | +58.4% |
| Stockholders' Equity | $302.3M | -0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.4M | -1.5% |
| Capital Expenditures | $12.0M | +496.0% |
| Investing Cash Flow | -$102.3M | -79.8% |
| Financing Cash Flow | -$9.6M | -105.1% |
| Free Cash Flow | $21.4M | -32.8% |
| -255.6% |